Ozempic, or Semaglutide, is primarily used for treating diabetes and obesity. It is also being explored for other applications, such as slowing down digestion and reducing appetite, potentially for conditions like addiction or arthritis.
The shortage is due to increased demand, with prescriptions exceeding the available supply. This has led to constraints at manufacturers and backmarket dealings.
CAR-T cells are engineered immune cells that have shown promise in fighting cancer by modifying lymphocytes to target tumor cells. They are personalized treatments approved by the FDA for certain types of cancer.
CAR-T cell therapy is not without drawbacks, including potential side effects and the risk of secondary lymphoma. Researchers are still exploring the best ways to optimize and revolutionize this treatment.
Nature's 10 for 2024 includes Muhammad Yunus, an economist turned interim leader of Bangladesh; Anna Abalkina, a Russian science sleuth investigating scientific fraud; Placide Mbala, an epidemiologist sounding the alarm on Mpox; and Caitlin Carras, who successfully campaigned for better pay for PhDs and postdocs in Canada.
Muhammad Yunus was included for his unexpected role as the interim leader of Bangladesh, following a student-led revolution demanding his leadership. He is now tasked with reforming the country's institutions and addressing corruption.
Anna Abalkina is a science sleuth who specializes in identifying fake papers, plagiarism, and hijacked journals. She has exposed international scientific fraud and has been instrumental in uncovering scams in the publishing industry.
Placide Mbala is an epidemiologist who led a team that identified a new strain of Mpox virus in the Democratic Republic of the Congo. His work has been crucial in raising alarms about the outbreak and coordinating the response to the virus.
Caitlin Carras led the Support Our Science campaign, which successfully pushed for the largest pay raise in 20 years for graduate students and postdocs in Canada. Her efforts also secured more government scholarships and increased funding for researchers.
In the first of our annual festive songs celebrating the science of the past year, we pay homage to Ozempic, or Semaglutide, that's able to tackle obesity, diabetes and potentially a whole lot more.
We gather an all-star cast and see how well they can remember some of the big science stories from 2024 in our annual festive quiz.
In the second of our festive songs, we look at CAR-T cells. These engineered immune cells have shown great promise at tackling cancer, but these treatments are not without their drawbacks.
Every year, Nature’s 10 highlights some of the people who have helped shape science over the past 12 months. We hear about a few of the people who made the 2024 list, including an economist who now needs to run a country, a Russian science-sleuth, a researcher who’s been sounding the alarm on Mpox, and a PhD student who won a salary bump for researchers in Canada.
*News Feature: *Nature’s 10)
Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.) Hosted on Acast. See acast.com/privacy) for more information.